Patents by Inventor Daniel Knauer

Daniel Knauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of 2 anti-SPARC antibodies to predict response to chemotherapy for pancreatic adenocarcinoma
    Patent number: 9091697
    Abstract: The invention provides anti-SPARC antibody-based techniques for predicting a response to chemotherapy.
    Type: Grant
    Filed: February 25, 2013
    Date of Patent: July 28, 2015
    Assignee: Abraxis BioScience, LLC
    Inventors: Vuong Trieu, Neil Desai, Daniel Knauer
  • SPARC ANGIOGENIC DOMAIN AND METHODS OF USE
    Publication number: 20140094416
    Abstract: The invention provides compositions and methods which exploit the discovery of the SPARC carboxy angiogenic domain.
    Type: Application
    Filed: November 12, 2013
    Publication date: April 3, 2014
    Applicant: Abraxis BioScience, LLC
    Inventors: Vuong Trieu, Daniel Knauer, Neil Desai
  • Use of 2 anti-SPARC antibodies to predict response to melanoma chemotherapy
    Patent number: 8383358
    Abstract: The invention provides anti-SPARC antibody-based techniques for predicting a response to chemotherapy.
    Type: Grant
    Filed: May 28, 2010
    Date of Patent: February 26, 2013
    Assignee: Abraxis BioScience, LLC
    Inventors: Vuong Trieu, Neil Desai, Daniel Knauer
  • SPARC ANGIOGENIC DOMAIN AND METHODS OF USE
    Publication number: 20120087910
    Abstract: The invention provides compositions and methods which exploit the discovery of the SPARC carboxy angiogenic domain.
    Type: Application
    Filed: March 11, 2010
    Publication date: April 12, 2012
    Applicant: ABRAXIS BIOSCIENCE, LLC
    Inventors: Vuong Trieu, Daniel Knauer, Neil Desai
  • USE OF 2 ANTI-SPARC ANTIBODIES TO PREDICT RESPONSE TO CHEMOTHERAPY
    Publication number: 20100310507
    Abstract: The invention provides anti-SPARC antibody-based techniques for predicting a response to chemotherapy.
    Type: Application
    Filed: May 28, 2010
    Publication date: December 9, 2010
    Applicant: Abraxis BioScience, LLC
    Inventors: Vuong Trieu, Neil Desai, Daniel Knauer